Search

everythinglearnresearchcommunity

for

Search:↓

Pygopus 2 helps ovarian cancer cells grow by aiding ribosomal RNA production, independent of Wnt signaling.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.

Spironolactone does not increase the risk of breast cancer recurrence.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

PCOS significantly harms married women's quality of life, affecting mental health, fertility, and body image.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

Early hair loss in men may signal broader health issues similar to PCOS in women.